Charles Schwab Investment Management Inc Axsome Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 328,034 shares of AXSM stock, worth $38.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
328,034
Previous 322,596
1.69%
Holding current value
$38.9 Million
Previous $29 Million
4.25%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
35.7MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$480 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$463 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$391 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$174 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$165 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.08B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...